Our blog is a timely voice for cancer patients, caregivers, and those seeking information about mesothelioma and asbestos-related topics. By providing relevant news, personal stories, and practical insights, we will further spread awareness and nurture hope with the goal of one day eliminating mesothelioma.

Treatment January 23, 2023 MAAC Staff
Dr. Harvey Berger stands tall in front of a background of mottled greenery.

A Firsthand Look at Cancer Drug Development With Dr. Harvey Berger

The history of mesothelioma treatment has had its ups and downs, but research brings us closer to a cure each year. Doctors and scientists…

Read More
Treatment April 15, 2021 MAAC Staff
ONCOS-102 for mesothelioma

FDA Fast Tracks ONCOS-102 for Mesothelioma

Researchers have found various immunotherapy drugs may be effective in treating mesothelioma. Most recently, a clinical trial testing immunotherapy drug ONCOS-102 showed promising results…

Read More
Treatment March 19, 2021 MAAC Staff
General practitioner vaccinating old patient in clinic

Mesothelioma Advocates Recommend Patients Receiving Immunotherapy Treatment Get COVID-19 Vaccine

The COVID-19 pandemic changed life in the United States about one year ago this week. Since then, scientists have worked tirelessly to develop vaccines…

Read More
Treatment January 14, 2021 MAAC Staff
TTFields for Mesothelioma

Expanding Availability of TTFields for Mesothelioma Patients

Tumor Treating Fields (TTFields) are a newer treatment option in the mesothelioma community. TTFields target mesothelioma cancer by producing low-intensity electrical currents. These disrupt…

Read More
Treatment December 22, 2020 MAAC Staff
GATA3 Biomarker Signals Survival Differences in Male and Female Mesothelioma Patients

GATA3 Biomarker Signals Survival Differences in Male and Female Mesothelioma Patients

Researchers in Australia studying the biomarker GATA3 found female patients with the biomarker typically have more favorable survival rates than male patients with the…

Read More
Treatment November 12, 2020 MAAC Staff
CAR T-Cell Phase 1 Trial for Mesothelioma Gains FDA Approval

CAR T-Cell Phase 1 Trial for Mesothelioma Gains FDA Approval

A new CAR T-cell therapy for mesothelioma patients has Food and Drug Administration (FDA) approval to begin phase 1 clinical trials. The Atara Biotherapeutics…

Read More
Treatment October 29, 2020 MAAC Staff
Upcoming Clinical Trial Testing Cancer Vaccine for Pleural Mesothelioma

UV1 Cancer Vaccine May Be a Treatment Option for Pleural Mesothelioma

A previous clinical trial used a cancer vaccine to treat prostate cancer. The results showed promise treating the cancer with minimal serious side effects.…

Read More
Treatment October 15, 2020 MAAC Staff
Immunotherapy Pretreatment for Pleural Mesothelioma

New Study Looks at Immunotherapy as a Pretreatment to Improve Mesothelioma Survival

Mesothelioma patients typically undergo a multimodal treatment plan. Multimodal therapy incorporates at least two different treatment options. Immunotherapy continues to show promise to improve…

Read More